APP and Alzheimer disease: Since in the ACH2.0 paradigm conventional AD is triggered when AβPP-derived iAβ crosses the T1 threshold, the reduction in the rate of its accumulation would result in the delay of the T1 crossing and, consequently, of the occurrence of the disease.